Foscavir™

Read the CMI leaflet (Opens in new tab) for facts you need to know before, during and after taking your medicine.

For more information about CMIs and how to read them, please visit How to read Consumer Medicine Information (CMI).

Treatment of cytomegalovirus (CMV) retinitis in patients with the acquired immunodeficiency syndrome (AIDS). INDICATIONS AS AT 11 NOVEMBER 1994: For treatment of cytomegalovirus (CMV) retinitis in patients with acquired immunodeficiency syndrome (AIDS); and treatment of aciclovir resistant herpes simplex virus (HSV) infections (defined by clinical trial or in-vitro resistance) in immunocompromised patients with human immunodeficiency virus (HIV) infection. NOTE: the indication for treatment of aciclovir resistant HSV infections in immunocompromised patients with HIV infections is based primarily on the results of one open label comparative study. This was of patients with HIV infections and herpetic lesions unresponsive to aciclovir administered intravenously for 10 days or more and in-vitro documented resistance to aciclovir. Eight patients were randomised to foscarnet (40mg/kg IV given eight hourly) and 6 were randomised to vidarabine 15mg/kg IV daily. The results showed a significant difference in favour of the foscarnet treatment group for clinical and virological endpoints, especially in time to complete healing of lesions and time to complete loss of pain. In 177 other patients treated with foscarnet in non-comparative studies, results were sufficiently similar to support the efficacy of foscarnet in this indication.

Source: ARTG

• Shelf lifetime is 24 Months
• Store below 25 degrees Celsius
• Do not Refrigerate

Source: ARTG

Non-composite pack

This medicine contains one component only.

Component

• Injection, solution
• Intravenous
• A clear colourless solution.

Source: ARTG

These medicine packs are available from a pharmacist and requires a prescription. It is Schedule 4: Prescription Only Medicine.?What is the medicines and poisons schedule?

All medicines and poisons in Australia are categorised by how they are made available to the public. Medicines with a low safety risk are usually less tightly controlled than medicines with a higher safety risk. This system is called ‘scheduling’. You can read more about the scheduling of medicines as well as the different scheduling categories on our Scheduling of medicines and poisons information page.

• 250mL X 1

Source: ARTG

This medicine is not listed on the Pharmaceutical Benefits Scheme (PBS). Talk to your pharmacist about how much it will cost.

Source: PBS

For the active ingredient: foscarnet

You should seek advice from your doctor or pharmacist about taking this medicine. They can help you balance the risks and the benefits of this medicine during pregnancy.

Source: AHT

If you experience a side effect from this medicine, tell your doctor or pharmacist. Or report it directly to the TGA (Therapeutic Goods Administration).

You can report side effects to your doctor, or directly at Report an adverse event or safety problem (Opens in new tab)

Source: ARTG

Healthdirect medicines information is not intended for use in an emergency. If you are suffering an acute illness, overdose, or emergency condition, call triple zero (000) and ask for an ambulance.

Reasonable care has been taken to provide accurate information at the time of creation. This information is not intended to substitute medical advice, diagnosis or treatment and should not be exclusively relied on to manage or diagnose a medical condition. Please refer to our terms and conditions (Opens in new tab).